Drugs / mouse prostate-specific membrane antigen plasmid DNA vaccine
mouse prostate-specific membrane antigen plasmid DNA vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00096629 | Nov 2003 → Apr 2018 | kidney cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mouse prostate-specific membrane antigen plasmid DNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00096629 ↗ |
| Modality | Vaccine | “mouse prostate-specific membrane antigen plasmid DNA vaccine” NCT00096629 ↗ |
| Route | Intramuscular | “mouse PSMA DNA vaccine IM once every 3 weeks for 3 doses” NCT00096629 ↗ |